Cooley advised Dutch Bros, and Latham & Watkins advised the underwriters. Dutch Bros Inc. (NYSE: BROS; Dutch Bros) announced the pricing of an underwritten offering of...
Dutch Bros’ $300 Million Class A Common Stock Offering
ACELYRIN’s $621 Million Initial Public Offering
Cooley advised ACELYRIN, and Davis Polk advised the joint book-running managers. ACELYRIN, INC. announced its upsized initial public offering of 34,500,000 shares of common stock at...
Angion’s Merger Agreement with Elicio Therapeutics
Cooley advised Angion on the deal. Angion, a clinical-stage biopharmaceutical company, announced its definitive merger agreement with Elicio Therapeutics. Elicio will merge with a wholly owned subsidiary...
Sweetgreen’s $364 Million Initial Public Offering
Latham & Watkins represented the underwriters in the offering while Cooley LLP represented sweetgreen. Sweetgreen, Inc. executed its initial public offering of Class A common stock at...